Nandro Alpha-Pharma

 

$70.07

Description

Description

Nandro

Specification
Common
Active substance Nandrolone Propionate
Indications Nandro is indicated for treatment of anemia’s, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure and Turner’s syndrome and prophylaxis of hereditary angioedema.
Dosage
Quantity
Unit
Time
Potency
Quantity 100
Unit Milligram/Milliliter
Packaging
Quantity 10
Unit Ampul
Type Carton
Presentation Each carton contains 5 or 10 ampoules of 1ml (100mg/ml)